Caribou Biosciences Secures $30,000,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=966eaba2-42c2-43ec-818b-f680ad883446 - Date
5/16/2016 - Company Name
Caribou Biosciences - Mailing Address
2929 7th Street Berkeley, CA 94710 USA - Company Description
Caribou is a developer of cellular engineering and analysis solutions based on CRISPR technologies. Caribou’s tools and technologies provide transformative capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and basic and applied biological research. - Website
http://www.cariboubio.com - Transaction Type
Venture Equity - Transaction Amount
$30,000,000 - Transaction Round
Series B - Proceeds Purposes
The proceeds from this financing will enable us to continue to expand our industry-leading CRISPR gene editing technology platform and accelerate our efforts in highly promising application areas in agriculture, therapeutics, biological research, and industrial biotechnology. - M&A Terms
- Venture Investor
Anterra Capital - Venture Investor
Heritage Group - Venture Investor
Maverick Capital - Venture Investor
Pontifax Fund - Venture Investor
Novartis Venture Fund - Venture Investor
F-Prime Capital - Venture Investor
Mission Bay Capital
